MAP Pharmaceuticals, Inc. (MAPP) Posts Wider than Expected Q1 Loss
Tweet
Share
E-mailGet Alerts MAPP Hot Sheet
Price: $28.16 +0.64%
Financial Fact:
Other expense, net: -3K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Other expense, net: -3K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
MAP Pharmaceuticals, Inc. (NASDAQ: MAPP) reported Q1 EPS of ($0.58), $0.19 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $1 million versus the consensus estimate of $1.1 million.
For earnings history and earnings-related data on MAP Pharmaceuticals, Inc. (MAPP) click here.
For earnings history and earnings-related data on MAP Pharmaceuticals, Inc. (MAPP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Is the global equity rally broadening? UBS weighs in
- Deutsche Bank monitors UK auto sales as Chinese exports grow
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
